Ignite Creation Date:
2024-05-05 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00413270
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2011-07-13
First Post:
2006-12-18
Brief Title:
Oral Nilotinib in Adults With Chronic Myeloid Leukemia CML in Blast Crisis Who Are Imatinib Resistant or Intolerant
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Chronic Myelogenous Leukemia |